Despite the Centers for Disease Control and Prevention warning this year will be potentially dangerous for respiratory illnesses, a third of Americans are not concerned about the threat,… read more.
Young people who have used e-cigarettes are more than twice as likely to report experiencing chronic stress, according to research Dr Teresa To from the Hospital for Sick… read more.
The cells of babies exposed to air pollution while in the womb show damage which may put them at risk of ill-health later in life, according to research… read more.
A new study from the Texas A&M University School of Public Health suggests that vaping increases the risk of asthma in adolescents who have never smoked conventional tobacco products. Vaping,… read more.
People who use both cannabis and tobacco have significantly higher rates of depression and anxiety than those who use either substance alone or not at all, according to… read more.
More than half of American adults have been recently exposed to secondhand tobacco smoke – and the vast majority of them were unaware, according to new research. Nationwide,… read more.
Nicotine e-cigarettes and two prescription medications that curb symptoms of withdrawal are the most effective stop-smoking aids, according to a comprehensive, multinational review by a team of scientists,… read more.
Positive results from the FLAURA2 Phase III trial showed AstraZeneca’s Tagrisso (osimertinib) in combination with chemotherapy demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS),… read more.
Babies and young children with more mature communities of bacteria present in their gut are less likely to develop allergy-related wheezing or asthma, according to research presented at… read more.
EU medicines regulators have approved a vaccine to protect against disease caused by the respiratory syncytial virus (RSV). Abrysvo is the first RSV vaccine indicated for passive immunisation… read more.
Researchers urge governments to raise the legal age to purchase cigarettes to 22 years or higher as study finds it becomes less addictive and easier to quit as… read more.
Pfizer announced that the European Commission (EC) has granted marketing authorization for Abrysvo, the company’s bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF) vaccine, to help protect both… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
